Targeted depletion of PD-1–expressing cells induces immune tolerance through peripheral clonal deletion
Science Immunology · 2024
DOI: 10.1126/sciimmunol.adh0085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2024. Verfasst von Jikai Cui und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, Clonal Deletion, Immune Tolerance, Mice, Inbred C57BL. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
Thymic negative selection of the T cell receptor (TCR) repertoire is essential for establishing self-tolerance and acquired allograft tolerance following organ transplantation. However, it is unclear whether and how peripheral clonal deletion of alloreactive T cells induces transplantation tolerance. Here, we establish that programmed cell death protein 1 (PD-1) is a hallmark of alloreactive T cells and is associated with clonal expansion after alloantigen encounter. Moreover, we found that diphtheria toxin receptor (DTR)–mediated ablation of PD-1 + cells reshaped the TCR repertoire through peripheral clonal deletion of alloreactive T cells and promoted tolerance in mouse transplantation models. In addition, by using PD-1–specific depleting antibodies, we found that antibody-mediated depletion of PD-1 + cells prevented heart transplant rejection and the development of experimental autoimmune encephalomyelitis (EAE) in humanized PD-1 mice. Thus, these data suggest that PD-1 is an attractive target for peripheral clonal deletion and induction of immune tolerance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.
- Center for Translational Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Immunobiology and Transplant Science Center, Department of Surgery, Houston Methodist Research Institute and Institute for Academic Medicine, Houston Methodist Hospital, Houston, TX, USA.
- Institute of Translational Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Jikai Cui, Heng Xu, Jizhang Yu, Shuan Ran, Yuqing Niu, Weicong Ye, Wenhao Chen, Jie Wu, Jiahong Xia
Zitieren
APA
Cui, J., Xu, H., Yu, J., Ran, S., Zhang, X., Li, Y., Chen, Z., Niu, Y., Wang, S., Ye, W., Chen, W., Wu, J., & Xia, J. (2024). Targeted depletion of PD-1–expressing cells induces immune tolerance through peripheral clonal deletion. Science Immunology. https://doi.org/10.1126/sciimmunol.adh0085
Vancouver
Cui J, Xu H, Yu J, Ran S, Zhang X, Li Y, et al. Targeted depletion of PD-1–expressing cells induces immune tolerance through peripheral clonal deletion. Science Immunology. 2024. doi:10.1126/sciimmunol.adh0085
BibTeX
@article{Cui2024,
author = {Cui, Jikai and Xu, Heng and Yu, Jizhang and Ran, Shuan and Zhang, Xi and Li, Yuan and Chen, Zhang and Niu, Yuqing and Wang, Song and Ye, Weicong and Chen, Wenhao and Wu, Jie and Xia, Jiahong},
title = {Targeted depletion of PD-1–expressing cells induces immune tolerance through peripheral clonal deletion},
journal = {Science Immunology},
year = {2024},
doi = {10.1126/sciimmunol.adh0085}
}
EUVIMED